Actinium Pharmaceuticals, Inc. (ATNM)
USD 1.16
(-4.92%)
USD 1.16
(-4.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 81 Thousand | 1.03 Million | 1.14 Million | - | - | - |
| Cost of Revenue | 790 Thousand | 699 Thousand | 524 Thousand | 447 Thousand | 420.08 Thousand | 50.72 Thousand |
| Gross Profit | -709 Thousand | 331 Thousand | 620 Thousand | -447 Thousand | -420.08 Thousand | -50.72 Thousand |
| Operating Expenses | 52 Million | 35.13 Million | 26.1 Million | 22.39 Million | 22.07 Million | 23.82 Million |
| Selling, General and Administrative Expenses | 13.33 Million | 11.99 Million | 8.07 Million | 6.3 Million | 5.52 Million | 6.73 Million |
| Research and Development Expenses | 38.67 Million | 23.13 Million | 18.03 Million | 16.08 Million | 16.54 Million | 17.09 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 52 Million | 35.13 Million | 26.1 Million | 22.39 Million | 22.07 Million | 23.82 Million |
| Operating Income | -51.92 Million | -34.1 Million | -24.96 Million | -22.39 Million | -22.07 Million | -23.82 Million |
| Interest Expense | - | - | - | - | - | 173.35 Thousand |
| Income Tax Expense | - | -1.08 Million | -190 Thousand | -178 Thousand | -172.39 Thousand | 173.35 Thousand |
| Earnings before Tax | -48.81 Million | -33.01 Million | -24.77 Million | -22.21 Million | -21.89 Million | -23.65 Million |
| Net Income | -48.81 Million | -31.93 Million | -24.58 Million | -22.03 Million | -21.72 Million | -23.65 Million |
| Earnings Per Share Basic | -1.83 | -1.32 | -1.20 | -1.82 | -4.37 | -6.69 |
| Earnings Per Share Diluted | -1.83 | -1.32 | -1.20 | -1.82 | -4.37 | -6.69 |
| Weighted Average Shares Outstanding | 26.6 Million | 24.14 Million | 20.56 Million | 12.13 Million | 4.97 Million | 3.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.6 Million | 24.14 Million | 20.56 Million | 12.13 Million | 4.97 Million | 3.53 Million |
| Gross Margin | -8.75 | 0.32 | 0.54 | - | - | - |
| EBIT Margin | -631.23 | -32.43 | -21.36 | - | - | - |
| Profit Margin | -602.69 | -31.00 | -21.49 | - | - | - |
| EBITDA | -51.13 Million | -33.4 Million | -24.44 Million | -21.76 Million | -21.47 Million | -23.77 Million |
| Earnings Before Tax Margin | -640.99 | -33.11 | -21.82 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 81 Thousand | 81 Thousand | - | - |
| Cost of Revenue | 189 Thousand | 216 Thousand | 199 Thousand | 790 Thousand | 200 Thousand | 209 Thousand |
| Gross Profit | -189 Thousand | -216 Thousand | -118 Thousand | -709 Thousand | -200 Thousand | -209 Thousand |
| Operating Expenses | 12.22 Million | 9.38 Million | 10.22 Million | 51.21 Million | 14.35 Million | 15.64 Million |
| Selling, General and Administrative Expenses | 3.59 Million | 2.96 Million | 2.3 Million | - | 2.72 Million | 4.56 Million |
| Research and Development Expenses | 8.63 Million | 6.41 Million | 7.91 Million | - | 11.62 Million | 11.08 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 12.41 Million | 9.59 Million | 10.42 Million | 52 Million | 14.35 Million | 15.64 Million |
| Operating Income | -12.41 Million | -9.59 Million | -10.34 Million | -51.92 Million | -14.35 Million | -15.64 Million |
| Interest Expense | - | - | 547 Thousand | - | - | - |
| Income Tax Expense | - | 172.72 Thousand | 547 Thousand | 622.1 Thousand | 239.58 Thousand | 86.91 Thousand |
| Earnings before Tax | -11.35 Million | -8.67 Million | -9.32 Million | -48.81 Million | -13.27 Million | -15.18 Million |
| Net Income | -11.35 Million | -8.67 Million | -9.32 Million | -48.81 Million | -13.27 Million | -15.18 Million |
| Earnings Per Share Basic | -0.38 | -0.31 | -0.34 | - | -0.49 | -0.58 |
| Earnings Per Share Diluted | -0.38 | -0.31 | -0.34 | - | -0.49 | -0.58 |
| Weighted Average Shares Outstanding | 30.1 Million | 27.88 Million | 27.63 Million | 26.6 Million | 27.05 Million | 26.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.1 Million | 27.88 Million | 27.63 Million | 26.6 Million | 27.05 Million | 26.21 Million |
| Gross Margin | - | - | -1.46 | -8.75 | - | - |
| EBIT Margin | - | - | -125.23 | - | - | - |
| Profit Margin | - | - | -115.11 | -602.69 | - | - |
| EBITDA | -12.22 Million | -9.38 Million | -10.14 Million | - | -14.15 Million | -15.43 Million |
| Earnings Before Tax Margin | - | - | -127.69 | -640.99 | - | - |
FAG
SNMSF
TIL
600071
VIPPYSP
LLD